The advancements in targets for ferroptosis in liver diseases

被引：4
|
作者：
Xiang, Xiaohong [1 ]
Gao, Jianbo [1 ]
Su, Danyang [1 ]
Shi, Doudou [2 ]
机构：
[1] Zhengzhou Univ, Dept Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Ninth Hosp Xian, Dept Geriatr, Xian, Shaanxi, Peoples R China
来源：
FRONTIERS IN MEDICINE | 2023年 / 10卷
关键词：
ferroptosis; targets; application; advancement; liver diseases; HEPATOCELLULAR-CARCINOMA; SORAFENIB; CELLS; NANOMATERIALS; INHIBITION; ACTIVATION; PATHWAY; STRESS;
D O I：
10.3389/fmed.2023.1084479
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ferroptosis is a type of regulated cell death caused by iron overload and lipid peroxidation, and its core is an imbalance of redox reactions. Recent studies showed that ferroptosis played a dual role in liver diseases, that was, as a therapeutic target and a pathogenic factor. Therefore, herein, we summarized the role of ferroptosis in liver diseases, reviewed the part of available targets, such as drugs, small molecules, and nanomaterials, that acted on ferroptosis in liver diseases, and discussed the current challenges and prospects.
引用
下载
收藏
页数：7
相关论文
共 50 条
  • [21] Neutrophils in liver diseases: pathogenesis and therapeutic targets
    Liu, Kai
    Wang, Fu-Sheng
    Xu, Ruonan
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (01) : 38 - 44
  • [22] Neutrophils in liver diseases: pathogenesis and therapeutic targets
    Kai Liu
    Fu-Sheng Wang
    Ruonan Xu
    Cellular & Molecular Immunology, 2021, 18 : 38 - 44
  • [23] Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases
    Kulkarni, Naveen M.
    Fung, Alice
    Kambadakone, Avinash R.
    Yeh, Benjamin M.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2021, 29 (03) : 305 - 320
  • [24] The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge
    Zhu, Lujian
    Luo, Shengnan
    Zhu, Yin
    Tang, Shiyue
    Li, Chenge
    Jin, Xiaozhi
    Wu, Faling
    Jiang, Huimian
    Wu, Lina
    Xu, Yejin
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 381 - 389
  • [25] Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases
    Ma, Chenhui
    Han, Li
    Zhu, Zheying
    Pang, Cheng Heng
    Pan, Guoyu
    BIOCHEMICAL PHARMACOLOGY, 2022, 205
  • [26] The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
    Ren, Yijing
    Li, Siyue
    Song, Zixuan
    Luo, Qiuping
    Zhang, Yingying
    Wang, Hao
    NUTRIENTS, 2022, 14 (11)
  • [27] Ferroptosis in senescence and age-related diseases: pathogenic mechanisms and potential intervention targets
    Chang Liu
    Jie Pan
    Qi Bao
    Molecular Biology Reports, 2025, 52 (1)
  • [28] Immunological mechanisms and therapeutic targets of fatty liver diseases
    Hua Wang
    Wajahat Mehal
    Laura E. Nagy
    Yaron Rotman
    Cellular & Molecular Immunology, 2021, 18 : 73 - 91
  • [29] Cholestatic liver diseases: new targets, new therapies
    Santiago, Priscila
    Scheinberg, Andrew R.
    Levy, Cynthia
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [30] Circular RNAs in liver diseases: Mechanisms and therapeutic targets
    Fu, Li-Yun
    Wang, Shu-Wei
    Hu, Meng-Yuan
    Jiang, Zhen-Luo
    Shen, Li-Li
    Zhou, Yu-Ping
    Guo, Jun-Ming
    Hu, Yao-Ren
    LIFE SCIENCES, 2021, 264
12345